| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4528499
Max Phase: Preclinical
Molecular Formula: C15H15N3O4S
Molecular Weight: 333.37
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCOC(=O)Cc1csc(N/N=C/c2ccc(C(=O)O)cc2)n1
Standard InChI: InChI=1S/C15H15N3O4S/c1-2-22-13(19)7-12-9-23-15(17-12)18-16-8-10-3-5-11(6-4-10)14(20)21/h3-6,8-9H,2,7H2,1H3,(H,17,18)(H,20,21)/b16-8+
Standard InChI Key: FNEMHFUPPXEXNT-LZYBPNLTSA-N
Associated Targets(non-human)
Leucine--tRNA ligase 91 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 333.37 | Molecular Weight (Monoisotopic): 333.0783 | AlogP: 2.39 | #Rotatable Bonds: 7 |
| Polar Surface Area: 100.88 | Molecular Species: ACID | HBA: 7 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.85 | CX Basic pKa: 4.78 | CX LogP: 2.23 | CX LogD: 0.14 |
| Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.46 | Np Likeness Score: -1.84 |
References
| 1. Kovalenko OP, Volynets GP, Rybak MY, Starosyla SA, Gudzera OI, Lukashov SS, Bdzhola VG, Yarmoluk SM, Boshoff HI, Tukalo MA.. (2019) Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazines., 10 (12): [PMID:32206244] [10.1039/C9MD00347A] |
Source
Source(1):